Blog

Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background

Oxford Cancer Biomarkers

OCB was created in 2012 by internationally renowned University of Oxford cancer professors, Nick La Thangue and David Kerr to revolutionise personalised medicine using ground-breaking biomarker technology. Our current tests are focussed on colorectal cancer diagnosis, management and treatment; we will be expanding our portfolio of tests to benefit other cancer treatment programmes.

www.oxfordbio.com